Nova Mentis Life Science Corp (NOVA.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
May 01, 16:00
Nova Mentis Life Science Net Income (TTM): -2.184M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -2.184M |
March 31, 2023 | -2.367M |
December 31, 2022 | -2.466M |
September 30, 2022 | -1.640M |
June 30, 2022 | -2.640M |
March 31, 2022 | -2.695M |
December 31, 2021 | -2.685M |
September 30, 2021 | -20.51M |
June 30, 2021 | -19.66M |
March 31, 2021 | -25.67M |
December 31, 2020 | -25.23M |
September 30, 2020 | -7.414M |
June 30, 2020 | -7.204M |
March 31, 2020 | -1.249M |
December 31, 2019 | -1.398M |
September 30, 2019 | -1.697M |
June 30, 2019 | -2.109M |
March 31, 2019 | -1.833M |
December 31, 2018 | -3.573M |
September 30, 2018 | -3.82M |
June 30, 2018 | -3.533M |
March 31, 2018 | -3.673M |
December 31, 2017 | -1.866M |
September 30, 2017 | -2.667M |
June 30, 2017 | -2.393M |
Date | Value |
---|---|
March 31, 2017 | -2.256M |
December 31, 2016 | -2.075M |
September 30, 2016 | -0.7167M |
June 30, 2016 | -0.6935M |
March 31, 2016 | -0.6066M |
December 31, 2015 | -0.6892M |
September 30, 2015 | -2.186M |
June 30, 2015 | -2.134M |
March 31, 2015 | -2.156M |
December 31, 2014 | -2.061M |
September 30, 2014 | -0.4159M |
June 30, 2014 | -0.3873M |
March 31, 2014 | -0.2787M |
December 31, 2013 | -0.2633M |
September 30, 2013 | -6.27M |
June 30, 2013 | -6.390M |
March 31, 2013 | -6.484M |
December 31, 2012 | -6.598M |
September 30, 2012 | -2.924M |
June 30, 2012 | -2.928M |
March 31, 2012 | -3.261M |
December 31, 2011 | -3.313M |
September 30, 2011 | -1.740M |
June 30, 2011 | -1.840M |
March 31, 2011 | -1.555M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-25.67M
Minimum
Mar 2021
-1.249M
Maximum
Mar 2020
-7.578M
Average
-2.640M
Median
Jun 2022
Net Income (TTM) Benchmarks
Biocure Technology Inc | 1.618M |
Core One Labs Inc | -6.004M |
Nanosphere Health Sciences Inc | -0.3596M |
Lobe Sciences Ltd | -6.192M |
Algernon Pharmaceuticals Inc | -6.734M |